- Home
- LGND vs CSAN Comparison
LGND vs CSAN Comparison
Compare LGND & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- CSAN
- Stock Information
- Founded
- LGND 1987
- CSAN 1936
- Country
- LGND United States
- CSAN Brazil
- Employees
- LGND 68
- CSAN N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- CSAN Retail-Auto Dealers and Gas Stations
- Sector
- LGND Health Care
- CSAN Consumer Discretionary
- Exchange
- LGND Nasdaq
- CSAN Nasdaq
- Market Cap
- LGND 2.2B
- CSAN 2.3B
- IPO Year
- LGND 1992
- CSAN N/A
- Fundamental
- Price
- LGND $147.40
- CSAN $4.34
- Analyst Decision
- LGND Strong Buy
- CSAN Strong Buy
- Analyst Count
- LGND 8
- CSAN 1
- Target Price
- LGND $144.71
- CSAN $19.00
- AVG Volume (30 Days)
- LGND 139.7K
- CSAN 1.4M
- Earning Date
- LGND 08-05-2025
- CSAN 08-11-2025
- Dividend Yield
- LGND N/A
- CSAN 7.19%
- EPS Growth
- LGND N/A
- CSAN N/A
- EPS
- LGND N/A
- CSAN N/A
- Revenue
- LGND $181,488,000.00
- CSAN $7,634,304,853.00
- Revenue This Year
- LGND $18.41
- CSAN $262.72
- Revenue Next Year
- LGND $18.87
- CSAN $2.62
- P/E Ratio
- LGND N/A
- CSAN N/A
- Revenue Growth
- LGND 53.40
- CSAN 10.28
- 52 Week Low
- LGND $81.74
- CSAN $4.01
- 52 Week High
- LGND $129.90
- CSAN $10.36
- Technical
- Relative Strength Index (RSI)
- LGND 68.73
- CSAN 44.05
- Support Level
- LGND $132.21
- CSAN $4.16
- Resistance Level
- LGND $149.21
- CSAN $4.40
- Average True Range (ATR)
- LGND 5.37
- CSAN 0.16
- MACD
- LGND 0.53
- CSAN 0.06
- Stochastic Oscillator
- LGND 83.70
- CSAN 89.61
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.